Sign In
Buy HIMS
$27.51
+0 (+0%)
At Close: Jun 03, 2026
Hims & Hers Health: Undervalued Company With Tremendous Upside
06:16am, Sunday, 12'th Jun 2022 Seeking Alpha
Hims & Hers is a rapidly growing Telehealth company which is providing significant value to its customers. Read on to know my valuation analysis and my recommendation.
Hims & Hers Health: Undervalued Company With Tremendous Upside
02:16am, Sunday, 12'th Jun 2022
Hims is a rapidly growing Telehealth company, which is providing significant value to its customers. The business has more positives going for it than negatives. The ever-declining stock price doesn't
Beware of This Dog Because Bark Has No Bite
03:45pm, Saturday, 04'th Jun 2022 The Motley Fool
The DTC pet-products company still can't produce a profit.
This Growth Stock Expects Sales to Rise by at Least 51% This Year
02:45pm, Wednesday, 25'th May 2022 The Motley Fool
Investors could be overlooking an attractive investment opportunity with Hims & Hers right now.
Hims & Hers: Improving Fundamentals + Declining Price = A Generational Buy
09:30am, Monday, 16'th May 2022
In this note, we will discuss Hims & Hers' Q1 2022 report. Hims & Hers is delivering exceptional numbers on almost all KPI metrics. The stock keeps going lower, but the fundamentals are improving with
Hims & Hers Health, Inc. (HIMS) Reports Q1 Loss, Tops Revenue Estimates
10:55pm, Monday, 09'th May 2022 Zacks Investment Research
Hims & Hers Health, Inc. (HIMS) delivered earnings and revenue surprises of 11.11% and 12.48%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stoc
Hims & Hers Health, Inc. (HIMS) CEO Andrew Dudum on Q1 2022 Results - Earnings Call Transcript
10:28pm, Monday, 09'th May 2022
Hims & Hers Health, Inc. (NYSE:HIMS ) Q1 2022 Earnings Conference Call May 9, 2022 5:00 PM ET Company Participants Jay Spitzer - Senior Vice President and Investor Relations Andrew Dudum - Co-Founder
Hims & Hers Health, Inc. (HIMS) Reports Q1 Loss, Tops Revenue Estimates
08:18pm, Monday, 09'th May 2022
Hims & Hers Health, Inc. (HIMS) delivered earnings and revenue surprises of 11.11% and 12.48%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stoc
Outset Medical, Inc. (OM) Reports Q1 Loss, Tops Revenue Estimates
10:35pm, Wednesday, 04'th May 2022 Zacks Investment Research
Outset Medical, Inc. (OM) delivered earnings and revenue surprises of -1.52% and 0.65%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Hims & Hers Health: 3 Keys to Earnings
12:03pm, Wednesday, 04'th May 2022 The Motley Fool
Big things could be happening at this telehealth company.
Hims & Hers Health: 3 Keys to Earnings
08:03am, Wednesday, 04'th May 2022
Big things could be happening at this telehealth company.
Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates
09:35pm, Tuesday, 03'rd May 2022 Zacks Investment Research
Pulmonx Corporation (LUNG) delivered earnings and revenue surprises of -16.22% and 14.07%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Will Hims & Hers Health, Inc. (HIMS) Report Negative Earnings Next Week? What You Should Know
07:00pm, Monday, 02'nd May 2022 Zacks Investment Research
Hims & Hers Health, Inc. (HIMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Hims & Hers Health, Inc. (HIMS) Report Negative Earnings Next Week? What You Should Know
04:33pm, Monday, 02'nd May 2022
Hims & Hers Health, Inc. (HIMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Things About Hims & Hers Health That Smart Investors Know
03:23pm, Tuesday, 19'th Apr 2022 The Motley Fool
Hims & Hers is a young company with a bright future ahead.
